Deals
Coherus Biosciences Raises $100M at 55% Premium From HealthCare Royalty Partners
|
Coherus Biosciences (NASDAQ GM:CHRS) announced that it has raised $100,000,000 in a Convertible Senior Secured Notes transaction.
Growth Capitalist (https://growthcapitalist.com/tag/biotech/page/10/)
Coherus Biosciences (NASDAQ GM:CHRS) announced that it has raised $100,000,000 in a Convertible Senior Secured Notes transaction.
Evolutionary Genomics (OTC:FNAM) announced that it has raised $2,159,567 in a Convertible Preferred Stock transaction.
Rexahn Pharmaceuticals (AMEX:RNN) announced that it has raised $5,000,000 in a Registered Direct transaction.
NovaBay Pharmaceuticals (AMEX:NBY) announced that it has raised $1,260,828 in a Common Stock transaction.